[1] |
Hernández-Cabanyero C, Amaro C. Phylogeny and life cycle of the zoonotic pathogen Vibrio vulnificus. Environ Microbiol, 2020; 22, 4133−48. doi: 10.1111/1462-2920.15137 |
[2] |
Heng SP, Letchumanan V, Deng CY, et al. Vibrio vulnificus: an environmental and clinical burden. Front Microbiol, 2017; 8, 997. doi: 10.3389/fmicb.2017.00997 |
[3] |
Baker-Austin C, Oliver JD. Vibrio vulnificus: new insights into a deadly opportunistic pathogen. Environ Microbiol, 2018; 20, 423−30. doi: 10.1111/1462-2920.13955 |
[4] |
Leng F, Lin SL, Wu W, et al. Epidemiology, pathogenetic mechanism, clinical characteristics, and treatment of Vibrio vulnificus infection: a case report and literature review. Eur J Clin Microbiol Infect Dis, 2019; 38, 1999−2004. doi: 10.1007/s10096-019-03629-5 |
[5] |
Hong GL, Wu B, Lu CJ, et al. Emergency treatment of 16 patients with necrotizing fasciitis caused by Vibrio vulnificus infection complicated with septic shock. Chin Med J (Engl), 2014; 127, 1984−6. |
[6] |
Bolognese AC, Yang WL, Hansen LW, et al. Inhibition of necroptosis attenuates lung injury and improves survival in neonatal sepsis. Surgery, 2018; 164, 110−6. doi: 10.1016/j.surg.2018.02.017 |
[7] |
Xu Q, Guo JJ, Li XG, et al. Necroptosis underlies hepatic damage in a piglet model of lipopolysaccharide-induced sepsis. Front Immunol, 2021; 12, 633830. doi: 10.3389/fimmu.2021.633830 |
[8] |
Sharma A, Matsuo S, Yang WL, et al. Receptor-interacting protein kinase 3 deficiency inhibits immune cell infiltration and attenuates organ injury in sepsis. Crit Care, 2014; 18, R142. doi: 10.1186/cc13970 |
[9] |
Duprez L, Takahashi N, Van Hauwermeiren F, et al. RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome. Immunity, 2011; 35, 908−18. doi: 10.1016/j.immuni.2011.09.020 |
[10] |
Kitur K, Parker D, Nieto P, et al. Toxin-induced necroptosis is a major mechanism of Staphylococcus aureus lung damage. PLoS Pathog, 2015; 11, e1004820. doi: 10.1371/journal.ppat.1004820 |
[11] |
González-Juarbe N, Gilley RP, Hinojosa CA, et al. Pore-forming toxins induce macrophage necroptosis during acute bacterial pneumonia. PLoS Pathog, 2015; 11, e1005337. doi: 10.1371/journal.ppat.1005337 |
[12] |
Yuan Y, Feng Z, Wang J. Vibrio vulnificus hemolysin: biological activity, regulation of vvhA expression, and role in pathogenesis. Front Immunol, 2020; 11, 599439. doi: 10.3389/fimmu.2020.599439 |
[13] |
Shuai WZ, Liu JF, Wu CL, et al. Vibrio vulnificus cytolysin induces necroptosis in immortalized bone marrow-derived macrophage through RIP1/MLKL pathway. Med J Chin PLA, 2018; 43, 419−23. (In Chinese |
[14] |
Patoli D, Mignotte F, Deckert V, et al. Inhibition of mitophagy drives macrophage activation and antibacterial defense during sepsis. J Clin Invest, 2020; 130, 5858−74. doi: 10.1172/JCI130996 |
[15] |
Qiu P, Liu Y, Zhang J. Review: the role and mechanisms of macrophage autophagy in sepsis. Inflammation, 2019; 42, 6−19. doi: 10.1007/s10753-018-0890-8 |
[16] |
Lee MA, Kim JA, Shin MY, et al. VvpM induces human cell death via multifarious modes including necroptosis and autophagy. J Microbiol Biotechnol, 2015; 25, 302−6. doi: 10.4014/jmb.1501.01007 |
[17] |
Malaguarnera L. Influence of resveratrol on the immune response. Nutrients, 2019; 11, 946. doi: 10.3390/nu11050946 |
[18] |
Meng TT, Xiao DF, Muhammed A, et al. Anti-inflammatory action and mechanisms of resveratrol. Molecules, 2021; 26, 229. doi: 10.3390/molecules26010229 |
[19] |
Li XJ, Yao YJ, Wang SC, et al. Resveratrol relieves chlorothalonil-induced apoptosis and necroptosis through miR-15a/Bcl2-A20 axis in fish kidney cells. Fish Shellfish Immunol, 2020; 107, 427−34. doi: 10.1016/j.fsi.2020.11.007 |
[20] |
Xu HC, Lv W, Wang LM, et al. Early protection by resveratrol in rat lung transplantation. Med Sci Monit, 2019; 25, 760−70. doi: 10.12659/MSM.912345 |
[21] |
Qin KW, Fu KF, Liu JF, et al. Vibrio vulnificus cytolysin induces inflammatory responses in RAW264.7 macrophages through calcium signaling and causes inflammation in vivo. Microb Pathog, 2019; 137, 103789. doi: 10.1016/j.micpath.2019.103789 |
[22] |
Qin KW, Han CF, Zhang H, et al. NAD+ dependent deacetylase Sirtuin 5 rescues the innate inflammatory response of endotoxin tolerant macrophages by promoting acetylation of p65. J Autoimmun, 2017; 81, 120−9. doi: 10.1016/j.jaut.2017.04.006 |
[23] |
Khoury MK, Gupta K, Franco SR, et al. Necroptosis in the pathophysiology of disease. Am J Pathol, 2020; 190, 272−85. doi: 10.1016/j.ajpath.2019.10.012 |
[24] |
Li G, Wang MY. The role of Vibrio vulnificus virulence factors and regulators in its infection-induced sepsis. Folia Microbiol (Praha), 2020; 65, 265−74. doi: 10.1007/s12223-019-00763-7 |
[25] |
Tang R, Xu J, Zhang B, et al. Ferroptosis, necroptosis, and pyroptosis in anticancer immunity. J Hematol Oncol, 2020; 13, 110. doi: 10.1186/s13045-020-00946-7 |
[26] |
Yuan JY, Amin P, Ofengeim D. Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases. Nat Rev Neurosci, 2019; 20, 19−33. doi: 10.1038/s41583-018-0093-1 |
[27] |
Zhang C, Feng YS, Qu SL, et al. Resveratrol attenuates doxorubicin-induced cardiomyocyte apoptosis in mice through SIRT1-mediated deacetylation of p53. Cardiovasc Res, 2011; 90, 538−45. doi: 10.1093/cvr/cvr022 |
[28] |
Jiang HB, Wang SM, Hou LK, et al. Resveratrol inhibits cell apoptosis by suppressing long noncoding RNA (lncRNA) XLOC_014869 during lipopolysaccharide-induced acute lung injury in rats. J Thorac Dis, 2021; 13, 6409−26. doi: 10.21037/jtd-21-1113 |
[29] |
Pal S, Shankar BS, Sainis KB. Cytokines from the tumor microenvironment modulate sirtinol cytotoxicity in A549 lung carcinoma cells. Cytokine, 2013; 64, 196−207. doi: 10.1016/j.cyto.2013.07.029 |
[30] |
Ugwu FN, Yu AP, Sin TK, et al. Protective effect of unacylated ghrelin on compression-induced skeletal muscle injury mediated by SIRT1-signaling. Front Physiol, 2017; 8, 962. doi: 10.3389/fphys.2017.00962 |
[31] |
Carafa V, Nebbioso A, Cuomo F, et al. RIP1-HAT1-SIRT complex identification and targeting in treatment and prevention of cancer. Clin Cancer Res, 2018; 24, 2886−900. doi: 10.1158/1078-0432.CCR-17-3081 |
[32] |
Yeung F, Hoberg JE, Ramsey CS, et al. Modulation of NF-κB-dependent transcription and cell survival by the SIRT1 deacetylase. Embo J, 2004; 23, 2369−80. doi: 10.1038/sj.emboj.7600244 |
[33] |
Kim SE, Kim HK, Choi SM, et al. In vitro Synergy and in vivo activity of tigecycline-ciprofloxacin combination therapy against Vibrio vulnificus sepsis. Antimicrob Agents Chemother, 2019; 63, e00310−19. |
[34] |
Da Silva LV, Ossai S, Chigbu P, et al. Antimicrobial and genetic profiles of Vibrio vulnificus and Vibrio parahaemolyticus isolated from the maryland Coastal Bays, United States. Front Microbiol, 2021; 12, 676249. doi: 10.3389/fmicb.2021.676249 |
[35] |
Elmahdi S, Dasilva LV, Parveen S. Antibiotic resistance of Vibrio parahaemolyticus and Vibrio vulnificus in various countries: a review. Food Microbiol, 2016; 57, 128−34. doi: 10.1016/j.fm.2016.02.008 |